Secreted frizzled-related protein 5 diminishes cardiac inflammation and protects the heart from ischemia/reperfusion injury

Journal of Biological Chemistry

Volumn 291, Issue 6, 2016, Pages 2566-2575

  Nakamura, Kazuto ^a   Sano, Soichi ^a   Fuster, José J ^a   Kikuchi, Ryosuke ^a   Shimizu, Ippei ^a   Ohshima, Kousei ^a   Katanasaka, Yasufumi ^a   Ouchi, Noriyuki ^a,b   Walsh, Kenneth ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH; GENE EXPRESSION; GENES; MACROPHAGES; MAMMALS; PROTEINS;

CANONICAL WNT SIGNALING; CARDIAC FUNCTIONS; CARDIAC MYOCYTES; DISEASE PROCESS; INFLAMMATORY GENE EXPRESSIONS; INFLAMMATORY RESPONSE; ISCHEMIA/REPERFUSION; WHITE ADIPOSE TISSUES;

HEART;

CHEMOKINE; CYTOKINE; SECRETED FRIZZLED RELATED PROTEIN 5; STRESS ACTIVATED PROTEIN KINASE; WNT5A PROTEIN; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; WNT PROTEIN; WNT5A PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW DERIVED MACROPHAGE; CARDITIS; CONTROLLED STUDY; ENZYME ACTIVATION; HEART FUNCTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REPERFUSION INJURY; ANIMAL; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; GENETICS; INFLAMMATION; KNOCKOUT MOUSE; MACROPHAGE; METABOLISM; MYOCARDITIS; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; INFLAMMATION; MACROPHAGES; MAP KINASE KINASE 4; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MYOCARDIAL ISCHEMIA; MYOCARDITIS; MYOCARDIUM; MYOCYTES, CARDIAC; SIGNAL TRANSDUCTION; WNT PROTEINS; WNT-5A PROTEIN;

EID: 84957991629     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.693937     Document Type: Article

References (58)

1. Ridker, P. M., and Lüscher, T. F. (2014) Anti-inflammatory therapies for cardiovascular disease. Eur. Heart J. 35, 1782-1791
2. Ouchi, N., and Parker., J. L., Lugus, J. J., and Walsh, K. (2011) Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 11, 85-97
3. Nakamura, K., and Fuster., J. J., and Walsh, K. (2014) Adipokines: a link between obesity and cardiovascular disease. J. Cardiol. 63, 250-259
4. Mortensen, R. M. (2012) Immune cell modulation of cardiac remodeling. Circulation 125, 1597-1600
5. Frangogiannis, N. G. (2012) Regulation of the inflammatory response in cardiac repair. Circ. Res. 110, 159-173
6. Nahrendorf, M., and Pittet., M. J., and Swirski, F. K. (2010) Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation 121, 2437-2445
7. Kawaguchi, M., Takahashi, M., Hata, T., Kashima, Y., Usui, F., Morimoto, H., Izawa, A., Takahashi, Y., Masumoto, J., Koyama, J., Hongo, M., Noda, T., Nakayama, J., Sagara, J., Taniguchi, S., and Ikeda, U. (2011) Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury. Circulation 123, 594-604
8. Shibata, R., Izumiya, Y., Sato, K., Papanicolaou, K., Kihara, S., Colucci, W. S., Sam, F., Ouchi, N., and Walsh, K. (2007) Adiponectin protects against the development of systolic dysfunction following myocardial infarction. J. Mol. Cell. Cardiol. 42, 1065-1074
9. Shibata, R., Sato, K., Pimentel, D. R., Takemura, Y., Kihara, S., Ohashi, K., Funahashi, T., Ouchi, N., and Walsh, K. (2005) Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat. Med. 11, 1096-1103
10. Kikuchi, A., Yamamoto, H., and Kishida, S. (2007) Multiplicity of the interactions of Wnt proteins and their receptors. Cell. Signal. 19, 659-671
11. Logan, C. Y., and Nusse, R. (2004) The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 20, 781-810
12. Rao, T. P., and Kühl, M. (2010) An updated overview on Wnt signaling pathways: a prelude for more. Circ. Res. 106, 1798-1806
13. van Amerongen, R. (2012) Alternative Wnt pathways and receptors. Cold Spring Harb. Perspect. Biol. 4, a007914
14. Gessert, S., and Kühl, M. (2010) The multiple phases and faces of wnt signaling during cardiac differentiation and development. Circ. Res. 107, 186-199
15. Malekar, P., Hagenmueller, M., Anyanwu, A., Buss, S., and Streit., M. R., Weiss, C. S., Wolf, D., Riffel, J., Bauer, A., Katus, H.A., and Hardt, S. E. (2010) Wnt signaling is critical for maladaptive cardiac hypertrophy and accelerates myocardial remodeling. Hypertension 55, 939-945
16. ter Horst, P., Smits, J. F., and Blankesteijn, W. M. (2012) The Wnt/Frizzled pathway as a therapeutic target for cardiac hypertrophy: where do we stand? Acta Physiol. (Oxf.) 204, 110-117
17. Bergmann, M. W.(2010) WNT signaling in adult cardiac hypertrophy and remodeling: lessons learned from cardiac development. Circ. Res. 107, 1198-1208
18. Kawano, Y., and Kypta, R. (2003) Secreted antagonists of the Wnt signalling pathway. J. Cell Sci. 116, 2627-2634
19. Finch, P.W., He, X., Kelley, M.J., Uren, A., Schaudies, R.P., Popescu, N.C., Rudikoff, S., and Aaronson., S. A., Varmus, H. E., and Rubin, J. S. (1997) Purification and molecular cloning ofa secreted, Frizzled-related antagonist of Wnt action. Proc. Natl. Acad. Sci. U.S.A. 94, 6770-6775
20. Melkonyan, H. S., and Chang., W. C., Shapiro, J. P., Mahadevappa, M., Fitzpatrick, P. A., Kiefer, M. C., Tomei, L. D., and Umansky, S. R. (1997) SARPs: a family of secreted apoptosis-related proteins. Proc. Natl. Acad. Sci. U.S.A. 94, 13636-13641
21. Mayr, T., Deutsch, U., Kühl, M., Drexler, H.C., Lottspeich, F., Deutzmann, R., Wedlich, D., and Risau, W. (1997) Fritz: a secreted frizzled-related protein that inhibits Wnt activity. Mech. Dev. 63, 109-125
22. Bovolenta, P., Esteve, P., Ruiz, J. M., Cisneros, E., and Lopez-Rios, J. (2008) Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease. J. Cell Sci. 121, 737-746
23. Rattner, A., and Hsieh., J. C., Smallwood, P. M., Gilbert, D. J., Copeland, N. G., Jenkins, N. A., and Nathans, J. (1997) A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors. Proc. Natl. Acad. Sci. U.S.A. 94, 2859-2863
24. Alfaro, M. P., Vincent, A., Saraswati, S., Thorne, C. A., Hong, C. C., Lee, E., and Young, P. P. (2010) sFRP2 suppression of bone morphogenic protein (BMP) and Wnt signaling mediates mesenchymal stem cell (MSC) self-renewal promoting engraftment and myocardial repair. J. Biol. Chem. 285, 35645-35653
25. He, W., Zhang, L., Ni, A., Zhang, Z., Mirotsou, M., Mao, L., Pratt, R. E., and Dzau, V. J. (2010) Exogenously administered secreted frizzled related protein 2 (Sfrp2) reduces fibrosis and improves cardiac function in a rat model of myocardial infarction. Proc. Natl. Acad. Sci. U.S.A. 107, 21110-21115
26. Barandon, L., Casassus, F., Leroux, L., Moreau, C, Allières, C, Lamazière, J. M., Dufourcq, P., Couffinhal, T., and Duplàa, C. (2011) Secreted frizzled-related protein-1 improves postinfarction scar formation through a modulation of inflammatory response. Arterioscler. Thromb. Vasc. Biol. 31, e80-87
27. Laeremans, H., and Hackeng., T. M., van Zandvoort, M. A., Thijssen, V. L., Janssen, B. J., Ottenheijm, H. C, Smits, J. F., and Blankesteijn, W. M. (2011) Blocking of frizzled signaling with a homologous peptide fragment of Wnt3a/Wnt5a reduces infarct expansion and prevents the development of heart failure after myocardial infarction. Circulation 124, 1626-1635
28. Ouchi, N., Higuchi, A., Ohashi, K., Oshima, Y., Gokce, N., Shibata, R., Akasaki, Y., Shimono, A., and Walsh, K. (2010) Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science 329, 454-457
29. Schulte, D. M., Müller, N., Neumann, K., Oberhäuser, F., Faust, M., Güdelhöfer, H., Brandt, B., Krone, W., and Laudes, M. (2012) Pro-inflammatory wnt5a and anti-inflammatory sFRP5 are differentially regulated by nutritional factors in obese human subjects. PLoS One 7, e32437
30. Jura, M., Jaroslawska, J., Chu, D. T., and Kozak, L. P. (2015) Mest and Sfrp5 are biomarkers for healthy adipose tissue. Biochimie 10.1016/j.biochi.2015.05.006
31. Flehmig, G., Scholz, M., Klöting, N, Fasshauer, M., Tönjes, A., Stumvoll, M., Youn, B. S., and Blüher, M. (2014) Identification of adipokine clusters related to parameters of fat mass, insulin sensitivity and inflammation. PLoS One 9, e99785
32. Hu, W., Li, L., Yang, M., Luo, X., Ran, W., Liu, D., Xiong, Z., Liu, H., and Yang, G. (2013) Circulating Sfrp5 is a signature of obesity-related metabolic disorders and is regulated by glucose and liraglutide in humans. J. Clin. Endocrinol. Metab. 98, 290-298
33. Prats-Puig, A., Soriano-Rodríguez, P., Carreras-Badosa, G., Riera-Pérez, E., Ros-Miquel, M., Gomila-Borja, A., de Zegher, F., Ibáñez, L., Bassols, J., and López-Bermejo, A. (2014) Balanced duo of anti-inflammatory SFRP5 and proinflammatory WNT5A in children. Pediatr. Res. 75, 793-797
34. Satoh, W., Matsuyama, M., Takemura, H., Aizawa, S., and Shimono, A. (2008) Sfrp1, Sfrp2, and Sfrp5 regulate the Wnt/β-catenin and the planar cell polarity pathways during early trunk formation in mouse. Genesis 46, 92-103
35. Maeda, N, Takahashi, M., Funahashi, T., Kihara, S., Nishizawa, H., Kishida, K., Nagaretani, H., Matsuda, M., Komuro, R., Ouchi, N, Kuriyama, H., Hotta, K., Nakamura, T., Shimomura, I., and Matsuzawa, Y. (2001) PPAR7 ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50, 2094-2099
36. Koza, R. A., Nikonova, L., Hogan, J., Rim, J. S., Mendoza, T., Faulk, C, Skaf J., and Kozak, L. P. (2006) Changes in gene expression foreshadow dietinduced obesity in genetically identical mice. PLoS Genet. 2, e81
37. Kambara, T., Ohashi, K., Shibata, R., Ogura, Y., Maruyama, S., Enomoto, T., Uemura, Y., Shimizu, Y., Yuasa, D., Matsuo, K., Miyabe, M., Kataoka, Y., Murohara, T., and Ouchi, N. (2012) CTRP9 protein protects against myocardial injury following ischemia-reperfusion through AMP-activated protein kinase (AMPK)-dependent mechanism. J. Biol. Chem. 287, 18965-18973
38. Ouchi, N, and Walsh, K. (2012) Cardiovascular and metabolic regulation by the adiponectin/C1q/tumor necrosis factor-related protein family of proteins. Circulation 125, 3066-3068
39. Wong, G. W., and Krawczyk., S. A., Kitidis-Mitrokostas, C, Ge, G., Spooner, E., Hug, C, Gimeno, R., and Lodish, H. F. (2009) Identification and characterization of CTRP9, a novel secreted glycoprotein, from adipose tissue that reduces serum glucose in mice and forms heterotrimers with adiponectin. FASEBJ. 23, 241-258
40. Shibata, R., Ouchi, N, Ito, M., Kihara, S., Shiojima, I., Pimentel, D. R., Kumada, M., Sato, K., Schiekofer, S., Ohashi, K., Funahashi, T., and Colucci., W. S., and Walsh, K. (2004) Adiponectin-mediated modulation of hyper-trophic signals in the heart. Nat Med. 10, 1384-1389
41. Sun, Y., Yi, W., Yuan, Y., Lau, W. B., Yi, D., Wang, X., Wang, Y., Su, H., Wang, X., Gao, E., Koch, W. J., and Ma, X. L. (2013) C1q/tumor necrosis factor-related protein-9, a novel adipocyte-derived cytokine, attenuates adverse remodeling in the ischemic mouse heart via protein kinase A activation. Circulation 128, S113-120
42. Leaf, I., Tennessen, J., Mukhopadhyay, M., Westphal, H, and Shawlot, W. (2006) Sfrp5 is not essential for axis formation in the mouse. Genesis 44, 573-578
43. Li, Y., and Rankin., S. A., Sinner, D., Kenny, A. P., Krieg, P. A., and Zorn, A. M. (2008) Sfrp5 coordinates foregut specification and morphogenesis by antagonizing both canonical and noncanonical Wnt11 signaling. Genes Dev. 22, 3050-3063
44. Kikuchi, R., Nakamura, K., MacLauchlan, S., Ngo, D. T., Shimizu, I., Fuster, J. J., Katanasaka, Y., Yoshida, S., Qiu, Y., Yamaguchi, T. P., Matsushita, T., Murohara, T., Gokce, N, and Bates., D. O., Hamburg, N. M., and Walsh, K. (2014) An antiangiogenic isoform of VEGF-A contributes to impaired vascularization in peripheral artery disease. Nat Med. 20, 1464-1471
45. Fuster, J. J., and Zuriaga., M. A., Ngo, D. T., Farb, M. G., Aprahamian, T., Yamaguchi, T. P., Gokce, N., and Walsh, K. (2015) Noncanonical Wnt signaling promotes obesity-induced adipose tissue inflammation and metabolic dysfunction independent of adipose tissue expansion. Diabetes 64, 1235-1248
46. Hagenmueller, M., Riffel, J. H, Bernhold, E., Fan, J., Katus, H. A., and Hardt, S. E. (2014) Dapper-1 is essential for Wnt5a induced cardiomyocyte hypertrophy by regulating the Wnt/PCP pathway. FEBS Lett. 588, 2230-2237
47. Rauner, M., Stein, N, Winzer, M., Goettsch, C, Zwerina, J., Schett, G., Distler, J. H, Albers, J., Schulze, J., Schinke, T., Bornhäuser, M., Platzbecker, U., and Hofbauer, L. C (2012) WNT5A is induced by inflammatory mediators in bone marrow stromal cells and regulates cytokine and chemokine production. J. Bone Miner. Res. 27, 575-585
48. Kim, J., Chang, W., Jung, Y., Song, K., and Lee, I. (2012) Wnt5a activates THP-1 monocytic cells via a β-catenin-independent pathway involving JNK and NF-KB activation. Cytokine 60, 242-248
49. Blumenthal, A., Ehlers, S, Lauber, J., Buer, J., Lange, C, Goldmann, T., Heine, H, Brandt, E., and Reiling, N. (2006) The Wingless homolog WNT5A and its receptor Frizzled-5 regulate inflammatory responses of human mononuclear cells induced by microbial stimulation. Blood 108, 965-973
50. Pereira, C, Schaer, D. J, Bachli, E. B., Kurrer, M. O., and Schoedon, G. (2008) Wnt5A/CaMKII signaling contributes to the inflammatory response of macrophages and is a target for the antiinflammatory action of activated protein C and interleukin-10. Arterioscler. Thromb. Vasc. Biol. 28, 504-510
51. Naskar, D., Maiti, G., Chakraborty, A., Roy, A., Chattopadhyay, D., and Sen, M. (2014) Wnt5a-Rac1-NF-κB homeostatic circuitry sustains innate immune functions in macrophages. J. Immunol. 192, 4386-4397
52. Pereira, C. P., and Bachli., E. B., and Schoedon, G. (2009) The wnt pathway: a macrophage effector molecule that triggers inflammation. Curr. Atheroscler. Rep. 11, 236-242
53. Han, M. S., and Jung., D. Y., Morel, C, and Lakhani., S. A., Kim, J. K., Flavell, R. A., and Davis, R. J. (2013) JNK expression by macrophages promotes obesityinduced insulin resistance and inflammation. Science 339, 218-222
54. Dawson, K., Aflaki, M., and Nattel, S. (2013) Role of the Wnt-Frizzled system in cardiac pathophysiology: a rapidly developing, poorly understood area with enormous potential. J. Physiol. 591, 1409-1432
55. Deb, A. (2014) Cell-cell interaction in the heart via Wnt/β-catenin pathway after cardiac injury. Cardiovasc. Res. 102, 214-223
56. Anunciado-Koza, R. P., Higgins, D. C, and Koza, R. A. (2015) Adipose tissue Mest and Sfrp5 are concomitant with variations of adiposity among inbred mouse strains fed a non-obesogenic diet. Biochimie 10.1016/j.biochi.2015.05.007
57. Wang, R., Hong, J., Liu, R., Chen, M., Xu, M., Gu, W., Zhang, Y., Ma, Q., Wang, F., Shi, J., Wang, J., Wang, W., and Ning, G. (2014) SFRP5 acts as a mature adipocyte marker but not as a regulator in adipogenesis. J. Mol. Endocrinol. 53, 405-415
58. Shibata, R., Sato, K., Kumada, M., Izumiya, Y., Sonoda, M., Kihara, S., Ouchi, N., and Walsh, K. (2007) Adiponectin accumulates in myocardial tissue that has been damaged by ischemia-reperfusion injury via leakage from the vascular compartment. Cardiovasc. Res. 74, 471-479